Javascript must be enabled to continue!
794. Healthcare-Associated Urinary Tract Infection (HA-UTI): A Risk Factor for Clostridioides difficile Infection (CDI)? Results of a Real-World Data Analysis
View through CrossRef
Abstract
Background
It is estimated that 223,900 cases of CDI occur annually in hospitalized patients resulting in 12,800 deaths and $1 billion in attributable costs. Antimicrobial use is a risk factor for CDI and the antimicrobials ordered to treat urinary tract infections have been identified as a factor in both recurrent CDI and community-acquired CDI. This real-world data analysis seeks to explore the relationship between HA-UTI and hospital-onset CDI (HO-CDI).
Methods
An electronic infection surveillance system was the source of de-identified real-world data from 290 hospitals. Algorithmically-derived measures of healthcare-associated infections (ADM-HAIs), and records of all-cause antimicrobial orders, for all inpatient admissions for the period 10/1/18–9/30/19 were analyzed. All patients who presented with a urine ADM-HAI – suggestive of HA-UTI – and no other healthcare-associated infection (Urine+ patients), were observed for subsequent HO-CDI. Urine+ patients were compared to patients with no HAI of any type, other than CDI (HAI-free patients), and relative risk (RR) was estimated. The analysis was repeated for the subgroup of patients who received an antimicrobial order for any reason during their stay.
Results
3,050,525 inpatient admissions were analyzed. 26,634 were identified as Urine+ patients. 188 of those patients subsequently presented with HO-CDI. 2,978,507 were identified as HAI-free patients. 6,238 of those patients presented with HO-CDI. The incidence of HO-CDI was significantly higher in Urine+ patients compared to HAI-free patients (RR=3.37, 95% CL[2.92, 3.89], p< 0.0001). When the analysis was repeated to examine only patients who received antimicrobial orders, Urine+ patients continued to be at higher risk of subsequent HO-CDI compared to HAI-free patients (RR=3.28, 95% CL[2.74,3.92], p< 0.0001).
Conclusion
The presence of a urine ADM-HAI, suggestive of HA-UTI, was associated with an increased risk of subsequent HO-CDI. This held when only patients with antimicrobial orders were considered. These observations mirror findings from other published studies, however, other factors may have contributed to increased risk for both HA-UTI and HO-CDI.
Disclosures
Timothy Kelly, MS, MBA, BD (Employee) ChinEn Ai, MPH, BD (Employee) John Murray, MPH, BD (Employee) Yan Xiong, n/a, BD (Becton Dickinson) (Employee) Hanna Jokinen-Gordon, PhD, BD (Employee)
Oxford University Press (OUP)
Title: 794. Healthcare-Associated Urinary Tract Infection (HA-UTI): A Risk Factor for Clostridioides difficile Infection (CDI)? Results of a Real-World Data Analysis
Description:
Abstract
Background
It is estimated that 223,900 cases of CDI occur annually in hospitalized patients resulting in 12,800 deaths and $1 billion in attributable costs.
Antimicrobial use is a risk factor for CDI and the antimicrobials ordered to treat urinary tract infections have been identified as a factor in both recurrent CDI and community-acquired CDI.
This real-world data analysis seeks to explore the relationship between HA-UTI and hospital-onset CDI (HO-CDI).
Methods
An electronic infection surveillance system was the source of de-identified real-world data from 290 hospitals.
Algorithmically-derived measures of healthcare-associated infections (ADM-HAIs), and records of all-cause antimicrobial orders, for all inpatient admissions for the period 10/1/18–9/30/19 were analyzed.
All patients who presented with a urine ADM-HAI – suggestive of HA-UTI – and no other healthcare-associated infection (Urine+ patients), were observed for subsequent HO-CDI.
Urine+ patients were compared to patients with no HAI of any type, other than CDI (HAI-free patients), and relative risk (RR) was estimated.
The analysis was repeated for the subgroup of patients who received an antimicrobial order for any reason during their stay.
Results
3,050,525 inpatient admissions were analyzed.
26,634 were identified as Urine+ patients.
188 of those patients subsequently presented with HO-CDI.
2,978,507 were identified as HAI-free patients.
6,238 of those patients presented with HO-CDI.
The incidence of HO-CDI was significantly higher in Urine+ patients compared to HAI-free patients (RR=3.
37, 95% CL[2.
92, 3.
89], p< 0.
0001).
When the analysis was repeated to examine only patients who received antimicrobial orders, Urine+ patients continued to be at higher risk of subsequent HO-CDI compared to HAI-free patients (RR=3.
28, 95% CL[2.
74,3.
92], p< 0.
0001).
Conclusion
The presence of a urine ADM-HAI, suggestive of HA-UTI, was associated with an increased risk of subsequent HO-CDI.
This held when only patients with antimicrobial orders were considered.
These observations mirror findings from other published studies, however, other factors may have contributed to increased risk for both HA-UTI and HO-CDI.
Disclosures
Timothy Kelly, MS, MBA, BD (Employee) ChinEn Ai, MPH, BD (Employee) John Murray, MPH, BD (Employee) Yan Xiong, n/a, BD (Becton Dickinson) (Employee) Hanna Jokinen-Gordon, PhD, BD (Employee).
Related Results
Impact of exposure to potentially contaminated hospital beds on risk of hospital-onset C. difficile infection
Impact of exposure to potentially contaminated hospital beds on risk of hospital-onset C. difficile infection
Background: Environmental contamination increases risk for Clostridioides difficile infection (CDI) given that spores can remain on a hospital bed, floor, sink, and light switch de...
A Retrospective Analysis of Risk Factors for Severe Clostridium Difficile Infection In Acute Leukemia and Aggressive Lymphoma.
A Retrospective Analysis of Risk Factors for Severe Clostridium Difficile Infection In Acute Leukemia and Aggressive Lymphoma.
Abstract
Abstract 3797
Introduction and Goals.
Clostridium difficile infection (CDI) is increasing in frequency a...
P035 Clostridium difficile infection in ulcerative colitis: Data from the tofacitinib clinical program and an insurance claims database
P035 Clostridium difficile infection in ulcerative colitis: Data from the tofacitinib clinical program and an insurance claims database
BACKGROUND:
Patients with inflammatory bowel disease (IBD), particularly ulcerative colitis (UC), have a higher risk of Clostridium difficile infection (CDI) than the g...
2824 Inpatient Fecal Microbiota Transplantation for the Treatment of Refractory Severe-Complicated Clostridioides difficile Infection
2824 Inpatient Fecal Microbiota Transplantation for the Treatment of Refractory Severe-Complicated Clostridioides difficile Infection
INTRODUCTION:
Currently, surgery is the primary treatment option for refractory, severe-complicated Clostridioides difficile infection (CDI) in the inpatient setting. T...
PROSPECTIVE ANALYSIS OF PRISCRIPTION PATTERN OF ANTIMICROBIAL THERAPY FOR URINARY TRACT INFECTIONS IN PREGNANT FEMALE PATIENT
PROSPECTIVE ANALYSIS OF PRISCRIPTION PATTERN OF ANTIMICROBIAL THERAPY FOR URINARY TRACT INFECTIONS IN PREGNANT FEMALE PATIENT
Pregnancy is a state of relative immunocompromise. This immunocompromise may be another cause for the increased frequency of UTIs seen in pregnancy. UTIs are one of the most common...
2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
Abstract
Background
Fecal microbiota transplantation (FMT) cures ~90% of patients with recurrent Clostridioides difficile infect...
P-1019. Comparative Analysis of C. difficile Isolates from Recurrent and Non-Recurrent Infections: Outcomes, Antimicrobial Susceptibility, and Biofilm Formation
P-1019. Comparative Analysis of C. difficile Isolates from Recurrent and Non-Recurrent Infections: Outcomes, Antimicrobial Susceptibility, and Biofilm Formation
Abstract
Background
Clostridioides difficile infection (CDI) is a serious diarrheal illness caused by microbiota disrupti...
Pet Ownership Protects Against Recurrence of Clostridioides difficile Infection
Pet Ownership Protects Against Recurrence of Clostridioides difficile Infection
Abstract
Background
Clostridioides difficile infection (CDI) is the leading cause of antibiotic-associated and health care–assoc...

